BB Biotech

BB Biotech is a publicly traded investment company that invests in fast growing and profitable biotech companies worldwide.

BB Biotech is a publicly traded investment company that invests in fast growing and profitable biotech companies worldwide. Established in 1993, BB Biotech is a pioneer in biotech investing and has grown to become one of the largest biotech investors. BB Biotech was one of the first investment companies in Europe to focus on the biotechnology industry. Since BB Biotech's foundation in 1993, they have offered investors direct access to a select portfolio of promising, fast growing and profitable biotech companies listed on stock markets around the world. BB Biotech's many years of expertise, their systematic approach and their clear focus has made them one of the world’s largest biotech investors and a European market leader. BB Biotech’s registered shares are listed on the SIX Swiss Exchange in Zurich, the Frankfurt Stock Exchange and the Stock Exchange in Milan, Italy. BB Biotech takes an active, bottom-up investment approach in managing a focused portfolio of approximately 30 stocks. BB Biotech's stated aim is to invest in the medicines of tomorrow and by extension, in the most promising and fastest growing companies in the biotech sector. BB Biotech's investment philosophy is focused on innovative drugs and therapies that offer sound value for the healthcare system. In the construction of the portfolio and the selection of core positions, they carefully consider risks associated with asset allocation and portfolio composition.The basic foundation of the portfolio is formed by established, highly profitable biotech companies, which account for a correspondingly high percentage of portfolio assets. Special attention is also given to small and mid-sized participations that have the means and the potential to eventually become one of the portfolio’s top holdings. To achieve successful investment results in the biotech sector, a combination of scientific, medical and financial expertise is needed. BB Biotech’s investment portfolio is managed by a team of investment specialists and analysts from different professional backgrounds, acting under the direction of the highly qualified Board of Directors. They maintain a global network of contacts with industry specialists, physicians, scientists and patent lawyers.